Prevalence of Anemia and Its Associated Factors Among Chronic Kidney Disease Patients Attending Selected Public Hospitals of Addis Ababa, Ethiopia: Institutional-Based Cross-Sectional Study

• Published in: International journal of nephrology and renovascular disease 2021-01, Vol.14, p.67-75
• Main Authors: Alemu, Birhie, Techane, Tesfaye, Dinegde, Negalign Getahun, Tsige, Yosief
• Format: Article
• Language: English
• Subjects: Age; Alcohol; Anemia; Body mass index; chronic kidney disease; Chronic kidney failure; Creatinine; Cross-sectional studies; Data collection; Diabetes; Disease susceptibility; Ethiopia; Exports; Health aspects; Hemodialysis; Hemoglobin; Hospitals; Hospitals, Public; Kidney diseases; Medical research; Medicine, Experimental; Morbidity; Mortality; Multivariate analysis; Original Research; prevalence; Prevalence studies (Epidemiology); Public health; Sample size; Smoking; Sociodemographics; South Korea
• ISSN: 1178-7058; 1178-7058
• DOI: 10.2147/IJNRD.S296995

Anemia is a global public health problem with high mortality and morbidity. It is becoming more prevalent in Ethiopia. Therefore, this study aimed to estimate the prevalence of anemia and its associated factors among chronic kidney disease patients at selected public hospitals of Addis Ababa, Ethiopia. An institutional-based cross-sectional study was conducted on selected public hospitals in Addis Ababa for studies on anemia in CKD patients. Data was entered into EPI Info version 4.4.1 and exported to SPSS version 24 for analysis. Both bivariate and multivariate logistic regression analyses were used to identify independently associated factors of anemia in CKD patients. Multivariate analysis was used to control the possible effect of confounders. A total of 387 participants were included to estimate the prevalence of anemia among chronic kidney disease patients. The prevalence of anemia was 53.5% (95% CI). Being females were 2 times more likely to develop anemia as compared to their counterparts (AOR=2.04, 95%:1.18, 2.46) and hemodialysis history had two times higher odds for anemia (AOR=2.754, 95% CI: 1.218-6.229, P=0.015) compared to patients without hemodialysis history. The overall prevalence of anemia across all stages of CKD is 53.5%. From the stage of CKD, stage 5 CKD has a higher (90.9%) anemia prevalence compared to others, and females showed a higher frequency of anemia when compared with males. Therefore, situation-based interventions and country context-specific preventive strategies should be developed to reduce the prevalence of anemia in this patient group.